Paul Sweetnam

Response Pharmaceuticals, Inc. is a clinical-stage therapeutic development company that focuses on developing treatments for weight management and metabolic disease. The company is based in Falls Church, VA. The company's initial clinical focus is to help people taking antipsychotic medications for disabling mental illness combat weight gain and metabolic dysregulation that is endemic with these treatments. Response is developing RDX-002 as an adjunctive therapy for patients taking first-line antipsychotic therapy. The company was founded by Eric Keller, Paul Sweetnam. Eric Keller has been the CEO since incorporation.

Surface Logix LLC is a drug development company which involves biophysical chemistry to create new small molecule drugs. It creates chemical entities and focuses on cardiovascular and metabolic diseases. The company was founded by George M. Whitesides and Carmichael S. Roberts, Jr. and is headquartered in Cambridge, MA.

University of Miami (Florida) is a private research university with students from around the world that is focused on teaching and learning, the discovery of new knowledge, and service to the South Florida region and beyond. The university was founded in 1925 and it is headquartered in Coral Gables, FL.

Part of Pfizer Inc., Pfizer Pharmaceuticals, Inc. is an American company that manufactures pharmaceutical products.